Find a Drug
Advanced Search

Professional

Accretropin

Drug Description
font size

Accretropin™
(somatropin) Injection

DRUG DESCRIPTION

Accretropin™ (recombinant human growth hormone (r-hGH); somatropin) is a protein produced by recombinant DNA technology. It is produced during fermentation in E. coli yielding a protein containing 192 amino acids. The N-terminal amino acid, methionine, is later removed to yield a protein that is chemically and physicochemically identical to pituitary derived human growth hormone, consisting of 191 amino acids in a single polypeptide chain.

Accretropin™ is distributed in a liquid solution containing 1 mL of a 5 mg/mL solution of growth hormone (15 IU/mL). The formulation also contains 0.75% NaCl, 0.34% Phenol (as preservative), 0.2% Pluronic F-68 (a non-ionic surfactant) and is designed for subcutaneous administration. Accretropin™ is stabilized to pH 6.0 with 10 mM NaPO4 buffer.

Brand Name: Accretropin
Generic Name: Somatropin Injection
Bookmark this page:


WebMD Symptom Checker - Start Here Diseases & Conditions: A comprehensive A-Z listing

Rethinking HRT Rethinking HRT
In 2002, researchers linked estrogen therapy to an increased risk for breast cancer, heart attack and stroke. Now it looks like the hormone is finding its way back into medicine cabinets. See more WebMD Videos »

WebMD Daily

Get breaking medical news.